Clinical study of Camrelizumab combined with Bevacizumab and DC-CIK in the treatment of advanced colorectal cancer

ABSTRACT: Interventions: single arm:camrelizumab, bevacizumab and DC-CIK Primary outcome(s): ORR Study Design: Single arm

DISEASE(S): Colorectal Cancer

PROVIDER: 2692527 | ecrin-mdr-crc |

REPOSITORIES: ECRIN MDR